- Home
- OPT vs RDVT Comparison
OPT vs RDVT Comparison
Compare OPT & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- RDVT
- Stock Information
- Founded
- OPT 1984
- RDVT 2017
- Country
- OPT Australia
- RDVT United States
- Employees
- OPT N/A
- RDVT N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- RDVT Computer Software: Prepackaged Software
- Sector
- OPT Health Care
- RDVT Technology
- Exchange
- OPT Nasdaq
- RDVT Nasdaq
- Market Cap
- OPT 574.0M
- RDVT 486.6M
- IPO Year
- OPT 2020
- RDVT N/A
- Fundamental
- Price
- OPT $3.90
- RDVT $35.45
- Analyst Decision
- OPT Strong Buy
- RDVT Strong Buy
- Analyst Count
- OPT 1
- RDVT 1
- Target Price
- OPT $12.00
- RDVT $25.00
- AVG Volume (30 Days)
- OPT 18.3K
- RDVT 51.1K
- Earning Date
- OPT 02-26-2025
- RDVT 03-06-2025
- Dividend Yield
- OPT N/A
- RDVT N/A
- EPS Growth
- OPT N/A
- RDVT N/A
- EPS
- OPT N/A
- RDVT 0.36
- Revenue
- OPT $261,859.00
- RDVT $70,685,000.00
- Revenue This Year
- OPT N/A
- RDVT $24.88
- Revenue Next Year
- OPT $46,864.26
- RDVT $14.52
- P/E Ratio
- OPT N/A
- RDVT $99.28
- Revenue Growth
- OPT N/A
- RDVT 21.43
- 52 Week Low
- OPT $1.79
- RDVT $16.56
- 52 Week High
- OPT $5.45
- RDVT $39.88
- Technical
- Relative Strength Index (RSI)
- OPT 56.41
- RDVT 48.43
- Support Level
- OPT $3.59
- RDVT $33.08
- Resistance Level
- OPT $3.90
- RDVT $36.13
- Average True Range (ATR)
- OPT 0.24
- RDVT 1.20
- MACD
- OPT 0.02
- RDVT -0.17
- Stochastic Oscillator
- OPT 74.11
- RDVT 55.63
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses, and assets.